CREDIT SUISSE AG/ - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 111 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$51,66018,000
+149900.0%
0.00%
Q2 2022$0
-100.0%
12
-100.0%
0.00%
Q4 2021$205,000
-52.0%
38,518
-23.9%
0.00%
Q3 2021$427,000
+89.8%
50,586
+444.3%
0.00%
Q1 2021$225,000
-70.5%
9,293
-61.0%
0.00%
Q4 2020$763,00023,8020.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q4 2020
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 634,191$1,820,1282.14%
NEA Management Company, LLC 4,448,757$12,767,9330.99%
CHI Advisors LLC 720,000$2,066,4000.82%
Bellevue Group AG 8,135,839$23,349,8580.38%
Parkman Healthcare Partners LLC 520,587$1,494,0850.27%
Artal Group S.A. 2,046,517$5,8740.25%
RA Capital Management 3,525,754$10,118,9140.20%
Ikarian Capital, LLC 555,572$1,594,4920.19%
TANG CAPITAL MANAGEMENT LLC 400,000$1,148,0000.16%
Newtyn Management, LLC 205,000$588,3500.14%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders